The latest brain, head and neck cancer news
New mRNA cancer vaccine triggers fierce immune response to malignant brain tumour
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed…
The latest brain, head and neck cancer news
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed…
Researchers from the University of Michigan Health Rogel Cancer Center, USA, have created a urine-based…
The Australian Government has awarded the Australian and New Zealand Children’s Haematology Oncology Group (ANZCHOG)…
Grant of up to $11 million will fund a clinical trial at University of California…
In a study of patients who smoked when they were diagnosed with laryngeal cancer, those…
Medulloblastoma (the most common malignant childhood brain tumour) is separated into four molecular groups, with…
TG4050, a personalised neoantigen vaccine, induced tumour-specific immune responses and led to low rates of…
AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both…
Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis…
Researchers at the University of Colorado School of Medicine, USA, are hopeful new research could…